From: 5α-reductase inhibitors impact prognosis of urothelial carcinoma
5-ARIs User, n (%) | None User, n (%) | P-value | |
---|---|---|---|
Case No. | 474 | 4740 | |
Variables | |||
Age (Mean ± SD) | 76.47 (±7.90) | 76.60 (±8.51) | 0.733 |
Age category (n, %) | |||
< 65 | 42 (8.86) | 466 (9.83) | |
65–74 | 153 (32.28) | 1387 (29.26) | |
> 75 | 279 (58.86) | 2887 (60.91) | |
CCI score (Mean ± SD) | 4.23 (±2.18) | 4.22 (±2.22) | 0.959 |
CCI score category | |||
0 ~ 3 | 220 (46.41) | 2203 (46.48) | |
4 ~ 7 | 202 (42.62) | 2037 (42.97) | |
8+ | 52 (10.97) | 500 (10.55) | |
Comorbidity | |||
Hypertension | 258 (54.43) | 2546 (53.71) | 0.765 |
Hyperlipidemia | 88 (18.57) | 842 (17.76) | 0.664 |
Diabetes mellitus | 114 (24.05) | 1121 (23.65) | 0.845 |
Chronic Kidney Disease | 36 (7.59) | 378 (7.97) | 0.771 |